Olufunmilayo Olopade was born in Nigeria in 1957 and was the fifth of six children born to an Anglican musician.
She attended St Anne's School in Ibadan for her secondary school education. Olopade first expressed her interest in becoming a doctor at a young age because the Nigerian villages were scarce for doctors and medical resources which were both in high demand.[6]
She works closely with the Breast Cancer Research Foundation[8] and has performed extensive clinical work surrounding the role of the BRCA1 and BRCA2 genes in the incidence of breast cancer in women of African descent.[9][2]
Olufunmilayo started her career in 1980 as a medical officer in the Nigerian Navy Hospital. She moved to the US in 1983 and worked at Cook County HospitalinChicago until 1987.[14] In 1991, Olufunmilayo joined the University of Chicago as an assistant professor in hematology and oncology, Dean of Global Health, and Director of the Center for Clinical Cancer Genetics at the University of Chicago.[15][7]
Olufunmilayo Olopade was one of the three African-Americans to receive the $500,000 award. This award was appointed by John D. and Catherine T. MacArthur Foundation. This "no strings attached" stipend grant was given as support for up to five years and was referred to as the "genius grant."[24] This grant allowed Olopade to continue her research on her groundbreaking discoveries on diseases and health concerns.
In 1983, she married Christopher Sola Olopade who is also a physician at the University of Chicago. They have two daughters, including journalistDayo Olopade, and one son.[25]
Most of her research was on the susceptibility to cancer which would then be used to adopt a more effective way of treating breast cancer among the African and African-American individuals and populations.[14]
In 1987 at the University of Chicago, she found a gene that helped suppress tumor growth.
In 1992, Olopade helped found the University of Chicago's Center for Clinical Cancer Genetics. Here, she found that African-American women often developed breast cancer at younger ages than white women.[26]
In 2003, she began a new study looking at breast cancer and genetics from African women from Nigeria to Senegal and also African-American women in Chicago. By 2005, she found that 80% of tumors in African women did not need estrogen to grow compared to 20% of tumors in Caucasian the women. She also found that this was due to a different pattern of gene expression between the African women and the Caucasian women.[27]
^"Olufunmilayo I. Olopade". AACR. American Association for Cancer Research. 2001. Archived from the original on September 29, 2013. Retrieved June 6, 2013.
^"News from the National Academy of Sciences". April 26, 2021. Retrieved July 5, 2021. Newly elected members and their affiliations at the time of election are: ... Olopade, Olufunmilayo F.; Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics, department of medicine, and director, Center for Clinical Genetics and Global Health, University of Chicago, Chicago, entry in member directory:"Member Directory". National Academy of Sciences. Retrieved July 5, 2021.
^Ikpatt, Offiong Francis; Olopade, Olufunmilayo I. (2006), Williams, Christopher Kwesi O.; Olopade, Olufunmilayo I.; Falkson, Carla I. (eds.), "Genetics of Breast Cancer in Women of African Descent: An Overview", Breast Cancer in Women of African Descent, Dordrecht: Springer Netherlands, pp. 23–37, doi:10.1007/978-1-4020-3664-4_2, ISBN978-1-4020-3664-4
